Back
Relmada Therapeutics 10K Form
Sell
40
RLMD
Relmada Therapeutics
Last Price:
3.72
Seasonality Move:
-13.22%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RLMD News And Ratings
See the #1 stock for the next 7 days that we like better than RLMD
RLMD Financial Statistics
Sales & Book Value
| Annual Sales: | $10K |
|---|---|
| Cash Flow: | $-10.25M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.84 |
| Price / Book: | 1.3 |
Profitability
| EPS (TTM): | -3.27000 |
|---|---|
| Net Income (TTM): | $-98.79M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Relmada Therapeutics Earnings Forecast
Key Relmada Therapeutics Financial Ratios
- The Selling, General & Administrative Expenses for RLMD have been equal to 500.00% of Gross Profit Margin.
- The Interest Expense is -9.27% of Operating Income.
- Per Share Earnings over the last 12 years have been positive in 5 years.
Relmada Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | RLMD |
| CUSIP: | 75955J |
| Website: | relmada.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
RLMD Technical Analysis vs Fundamental Analysis
Sell
40
Relmada Therapeutics (RLMD)
is a Sell
Is Relmada Therapeutics a Buy or a Sell?
-
Relmada Therapeutics stock is rated a Sell
The current Relmada Therapeutics [RLMD] share price is $3.69. The Score for RLMD is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.